|
Volumn 112, Issue 6 SUPPL. 1, 2002, Pages 19-27
|
Rhinovirus respiratory infections and asthma
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ALPHA2 INTERFERON;
ANTIVIRUS AGENT;
CYTOKINE;
IMMUNOGLOBULIN E;
INTERCELLULAR ADHESION MOLECULE 1;
PROTEINASE INHIBITOR;
UNCLASSIFIED DRUG;
VIRUS CAPSID BINDING AGENT;
ASTHMA;
ATOPY;
CELL ACTIVITY;
CLINICAL TRIAL;
CONFERENCE PAPER;
CYTOKINE PRODUCTION;
DISEASE ASSOCIATION;
DISEASE EXACERBATION;
HUMAN;
IMMUNE RESPONSE;
IMMUNOLOGY;
LUNG DISEASE;
METHODOLOGY;
MORBIDITY;
NEUTROPHIL;
PATHOGENESIS;
PHYSIOLOGY;
PRIORITY JOURNAL;
RESPIRATORY FUNCTION;
RESPIRATORY TRACT INFECTION;
RESPIRATORY TRACT INFLAMMATION;
REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;
RHINOVIRUS;
RISK FACTOR;
SEASONAL VARIATION;
SYMPTOM;
TEMPERATURE;
VIROGENESIS;
VIRUS DETECTION;
VIRUS IDENTIFICATION;
VIRUS INFECTION;
VIRUS ISOLATION;
|
EID: 0037156482
PISSN: 00029343
EISSN: None
Source Type: Journal
DOI: 10.1016/s0002-9343(01)01060-9 Document Type: Conference Paper |
Times cited : (78)
|
References (27)
|